PIK3CA and squamous cell lung carcinoma: This preferential activity in H23/H460 lines correlates with PIK3CA alterations prevalent in 33.1% of lung squamous cell carcinomas [42] which sensitize tumors to PI3K/Akt pathway modulation [47].